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Abstract
Background: Fusion of DNA methyltransferase domains to the nuclease-deficient clustered regularly interspaced short
palindromic repeat (CRISPR) associated protein 9 (dCas9) has been used for epigenome editing, but the specificities of these
dCas9 methyltransferases have not been fully investigated. Findings: We generated CRISPR-guided DNA methyltransferases
by fusing the catalytic domain of DNMT3A or DNMT3B to the C terminus of the dCas9 protein from Streptococcus pyogenes
and validated its on-target and global off-target characteristics. Using targeted quantitative bisulfite pyrosequencing, we
prove that dCas9-BFP-DNMT3A and dCas9-BFP-DNMT3B can efficiently methylate the CpG dinucleotides flanking its target
sites at different genomic loci (uPA and TGFBR3) in human embryonic kidney cells (HEK293T). Furthermore, we conducted
whole genome bisulfite sequencing (WGBS) to address the specificity of our dCas9 methyltransferases. WGBS revealed that
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although dCas9-BFP-DNMT3A and dCas9-BFP-DNMT3B did not cause global methylation changes, a substantial number
(more than 1000) of the off-target differentially methylated regions (DMRs) were identified. The off-target DMRs, which were
hypermethylated in cells expressing dCas9 methyltransferase and guide RNAs, were predominantly found in promoter
regions, 5′ untranslated regions, CpG islands, and DNase I hypersensitivity sites, whereas unexpected hypomethylated
off-target DMRs were significantly enriched in repeated sequences. Through chromatin immunoprecipitation with massive
parallel DNA sequencing analysis, we further revealed that these off-target DMRs were weakly correlated with dCas9
off-target binding sites. Using quantitative polymerase chain reaction, RNA sequencing, and fluorescence reporter cells, we
also found that dCas9-BFP-DNMT3A and dCas9-BFP-DNMT3B can mediate transient inhibition of gene expression, which
might be caused by dCas9-mediated de novo DNA methylation as well as interference with transcription. Conclusions: Our
results prove that dCas9 methyltransferases cause efficient RNA-guided methylation of specific endogenous CpGs.
However, there is significant off-target methylation indicating that further improvements of the specificity of CRISPR-dCas9
based DNA methylation modifiers are required.
Keywords: DNA methylation; CRISPR; Cas9; DNMT3A; DNMT3B; dCas9; specificity; off-targets; epigenome editing
Background
Owing to its simplicity, efficiency, and potential for multiplic-
ity, the type II clustered regularly interspaced short palindromic
repeats (CRISPR) and CRISPR-associated protein 9 (Cas9) with
engineered variants have been widely used for genome and
epigenome editing in many species [1–5]. The Cas9 protein is
guided to a specific genomic locus containing a protospacer ad-
jacent motif (PAM) by a small single guide RNA (gRNA), which
contains a conserved scaffold sequence and a programmable
guide sequence (typically 20 nt) for base pairing with the
target [1]. By introducing double mutations (D10A and H840A)
in the Streptococcus pyogenes Cas9 protein (dCas9) to inacti-
vate its catalytic activity and fusing functional effectors to the C
terminus of the dCas9, the applications of CRISPR/Cas9 are ex-
panded to regulation of gene expression (CRISPRa and CRISPRi)
[6–8], targeted DNA purification [9], visualization of specific
gene regions [10], and acetylation or methylation of chromatin
components [11, 12].
Genome-wide studies have revealed fundamental functional
roles of DNA methylation as well as associations between aber-
rant DNA methylation and human diseases including cancer
[13, 14]. Methylation of cytosine residues (5mC) in the mam-
malian genome mainly occurs at CpG dinucleotides. In pro-
moter regions, CpG methylation is normally associated with
repression of gene expression. Currently, insights into DNA
methylation-associated biological processes are largely based
on correlative data. Methods have been developed to methy-
late desired gene loci selectively by fusing programmable DNA
binding proteins (zinc finger proteins [ZFs] or transcription-
activator–like effectors [TALEs]) toDNAmethyltransferases [3–9].
However, the laborious generation of ZFs and TALEs hampers
their broader applications. Engineered dCas9 has been har-
nessed for targeted DNAmethylation by fusing dCas9 to the cat-
alytic domain ofmammalianDNAmethyltransferases, thus pro-
viding an alternative tool for more easily programmable DNA
methylation [15, 16].
Currently, genome-wide characterization of the specificity
of dCas9-based epigenetic modifiers is lacking. To gain more
insights into the efficiency and specificity of targeted DNA
methylation by CRISPR gRNA-guided dCas9 methyltransferases,
we used quantitative bisulfite pyrosequencing, whole genome
bisulfite sequencing, and ChIP-seq to investigate the character-




Human embryonic kidney HEK293T cells (American Type Cul-
ture Collection) were cultured in Dulbecco’s modified Eagle’s
medium (DMEM, Life Technologies), 10% fetal bovine serum
(Sigma), 1% penicillin-streptomycin (Sigma), and 1X GlutaMAX
(Life Technologies) at 37◦C, 5% CO2.
dCas9 methyltransferases plasmids
The dCas9 coding sequence was derived from pHR-SFFV-
dCas9-BFP-KRAB (Addgene ID 46911) (a gift from Stanley Qi
and Jonathan Weissman). The catalytic domains of DNMT1,
DNMT3A, and DNMT3B were polymerase chain reaction (PCR)–
amplified from pcDNA3/Myc-DNMT1 (Addgene ID 36939),
pcDNA3/Myc-DNMT3A (Addgene ID 35521), and pcDNA3/Myc-
DNMT3B1 (Addgene ID 35522) (a gift from Arthur Riggs),
respectively. The DNMT3A (E752A) and DNMT3B (E697A)
catalytically inactivating mutations were introduced by site-
directed mutagenesis. All plasmids described in this study have
been validated by Sanger sequencing and will be publically
available through Addgene [17] (Supplementary Table S1).
CRISPR gRNA design
Based on the observation that dCas9 methyltransferases could
efficiently methylate the CpGs flanking the target sites, a web-
based gRNA designing tool (dCas9 methyltransferases gRNA
finder, [18]) was developed to facilitate dCas9methyltransferase-
based gRNA design. All updates regarding the dCas9 methyl-
transferase protocol are available on the web site [19]. All gRNA
sequences are listed in Supplementary Table S1.
Transfection and enrichment transfected cells
Unless stated elsewhere, cells were transfected with gRNAs (to-
tal 500 ng) and a dCas9 methyltransferase expression vector
(500 ng) in 6-well plates using X-tremeGENE 9 DNA transfec-
tion reagent (Roche). For single gRNA or pUC19 control trans-
fections, the amount of plasmid added was equivalent to the to-
tal amount of plasmid added for multiple gRNA transfections.
For BFP-based enrichment, cells were harvested 48 hours af-
ter transfection, and dCas9 methyltransferase-expressing cells
were sorted by fluorescence activated cell sorting (FACS). Briefly,
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transfected cellswere harvested by trypsinization,washed twice
with 2% fetal bovine serum – phosphate-buffered saline (FBS-
PBS), and resuspended in 500 μL 2% FBS-PBS. Cells were stained
with propidium iodide (PI) before sorting. PI-negative and BFP-
positive or -negative cells were sorted with a 4 Laser BD FACS
Aria III instrument. All transfections were performed in at least
2 independent experiments.
Quantitative PCR
Total RNAwas extracted from cells with the RNeasy PlusMini kit
(Qiagen, 74136) according to themanufacturer’s instructions and
quantified using a Nanodrop 1000 spectrophotometer. The first
strand cDNA was synthesized from 100–500 ng total RNA with
the iScript cDNA synthesis kit (Bio-Rad, 170–8891) following the
manufacturer’s instructions. Quantitative PCR (qPCR) was per-
formed in triplicate for each sample, using the Light Cycler 480
SYBR Green I Master mix (Roche Life Science, 04887352001) and
a Light Cycler 480 qPCR machine. Each qPCR reaction contained
1 μL cDNA template (5 times diluted), 7.5 μL qPCR Master mix
(2X), and 5 pmol of each qPCR primer in a total volume of 15
μL. The following qPCR program was used for uPA, TGFBR3, and
GAPDH: 1 cycle at 95◦C for 5 minutes; 45 cycles at 95◦C for 10
seconds, 57◦C for 10 seconds, and 72◦C for 10 seconds during
which the fluorescence signal was measured. The final product
was subjected to melting curve analysis. Primers for qPCR are
listed in Supplementary Table S1. Relative gene expression was
calculated using the 2−CT method by first normalizing to the
internal control GAPDH (CT) and then calibrating to the trans-
fection control pUC19 (CT) [20].
DNA methylation analysis by bisulfite pyrosequencing
with PyroMark Q24
Genomic DNA was extracted using the DNeasy Blood & Tissue
kit (Qiagen, 69506) according to themanufacturer’s instructions.
A total of 200 ng of genomic DNA was bisulfite treated using
the EpiTect Bisulfite kit (Qiagen, 59104) according to the man-
ufacturer’s instructions. This converts unmethylated cytosines
to uracils. The bisulfite converted DNA was eluted with 20 μL
elution buffer provided in the kit. Bisulfite PCR reactions for all
genes described in this study were performed in a 25 μL volume
containing 0.15 μL Hotstar Taq polymerase (5 U/μL) (New Eng-
land Biolabs, M0495L), 2.5 μL 10× Standard buffer, 0.5 μL of 10
mM dNTPs, 1.0 μL of each primer (10 μM), and 1.5 μL bisulfite
converted genomic DNA. PCR was performed under the follow-
ing conditions: 95◦C for 5 minutes followed by 45 cycles at 94◦C
for 30 seconds, 58◦C for 1 minute, and 72◦C for 45 seconds, and,
finally, at 72◦C for 7 minutes. The 4 μL PCR product was checked
using gel electrophoresis. Pyrosequencing was performed with
the PyroMark Q24 Advanced Reagents (Qiagen, 970922) using 20
μL PCR product from the bisulfite treated DNA and 20 μL se-
quencing primer (0.375 μM) according to the PyroMark Q24 CpG
protocol. The general degree of cytosine methylation was de-
termined by pyrosequencing of the bisulfite converted genomic
DNA using the PyroMark Q24 Advanced System (Qiagen).
DNA methylation analysis by bisulfite Sanger
sequencing
Bisulfite converted DNA was used as the template for PCR am-
plifications with the BS-specific PCR primers listed in Supple-
mentary Table S1, using the DreamTaq DNA Polymerase (Life
Technologies, EP0701). PCR products were gel purified, sub-
cloned in a TA-cloning vector (Life Technologies, 450030), and
transformed into chemically competent Escherichia coli cells. Cell
clones were manually picked, subcultured in 250 uL LB medium
overnight, lysed, subjected to Sanger sequencing, and analyzed
using BISMA [21].
Fluorescence reporter cell assay
Five stable fluorescence reporter cell clones were established by
randomly inserting various copies of the CMV promoter-driven
mCherry expression cassette into HEK293T (pLV-mCherry was a
gift from Pantelis Tsoulfas, Addgene ID 36084). Cells were trans-
fected separately with each dCas9methyltransferase expression
vector (50 ng) and gRNAs (total 50 ng) in 24-well plates. One-
third of the transfected cells were seeded to a new plate ev-
ery 2–3 days, and the remainder was used for flow cytometry
analysis. Median mCherry intensity was measured with the BD
LSRFortessa cell analyzer (FACS CORE facility, Aarhus Univer-
sity). Identical instrument settings and control beads were ap-
plied during the time course experiment to ensure valid compar-
ison across different time points. A total of 20 000 events were
recorded for each sample. Flow cytometry data were analyzed
using Flowjo software.
Immunostaining
Forty-eight hours after transfection, cells were fixedwith freshly
made 4% paraformaldehyde for 15 minutes at room tempera-
ture, followed by 3 washes with Dulbecco’s phosphate-buffered
saline (DPBS). Cells were permeabilized in 0.3% Triton X-100
DPBS for 10 minutes and blocked in 5% goat serum–DPBS for 30
minutes. Cells were incubated with a primary rabbit anti-HA-
tag antibody (C29F4, Cell Signaling 3724, 1:1000) overnight, fol-
lowed by secondary antibody staining with Alexa Fluor 555 don-
key anti-rabbit immunoglobulin G (A-31572, Life Technologies)
at room temperature for 2 hours. Images were obtained with a
confocal microscope (LSM710, Carl Zeiss).
Southern blot analysis
GenomicDNA (15μg)was digestedwith EcoRI restriction enzyme
overnight and then analyzed using gel electrophoresis with vac-
uum blotting. Primers for generating the mCherry probe are
listed in Supplementary Table S1. Probe labeling was performed
using the Prime-It II RandomPrimer Labeling kit according to the
manufacturer’s instructions. Prehybridization and hybridization
steps were carried out at 42◦C. Excess probe was washed from
the membrane with saline-sodium citrate buffer, and the hy-
bridization pattern was visualized on X-ray film by autoradio-
graphy.
RNA sequencing
Integrity and quantity of extracted RNA was evaluated with an
Agilent 2100 Bioanalyzer according to the manufacturer’s in-
structions. After DNase I treatment, mRNA was isolated with
Oligo (dT) magnetic beads. Fragmentation buffer was added to
generate short fragments of mRNA. cDNA was synthesized us-
ing the mRNA fragments as templates, resolved with EB buffer
for end repair and ligated with adaptors. After size selection and
purification by agarose gel electrophoresis, cDNA with sizes of
approximately 240 bp were used for PCR amplification (12 cy-
cles) and library construction. Libraries were sequenced on an
Ion Proton platform (>30 million reads per sample). Sequencing
reads that contained low-quality, adaptor, and/or short (<30 nt)
read sequences were filtered out before mapping. Then, tmap
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was used to align the clean reads to the hg19 UCSC RefSeq
(RNA sequences, GRCh37). No more than 3 mismatches were al-
lowed in the alignment. Gene expression levels were calculated
by transforming uniquely mapped transcript reads to transcript
per million [22]. Differentially expressed genes were defined as
genes with a Benjamini-Hochberg–adjusted P value false discov-
ery rate (FDR) ≤0.001 and fold change ≥2 compared to pUC19
control.
ChIP-seq
HEK293T cells were transfected with dCas9 methyltransferase
and % uPA gRNAs (triplicates). Forty-eight hours after trans-
fection, transfected cells were subjected to ChIP with a com-
mercially available kit ChIP-IT Express Enzymatic (53009-AF,
ActivMotif, distributed by Nordic Biolabs) and an anti-HA tag
antibody (C29F4, Cell Signaling) according to the manufac-
turer’s instructions. Next-generation sequencing libraries were
prepared for Chip and input samples. SE50 sequencing was
performed on Illumina HiSeq2500. Clean reads were mapped
to human genome hg19 using SOAP2 with the parameter “-
p 4 -v 2 -s 35.” Unique mapping reads were sampled ran-
domly and equally (62 723 057 reads). Peaks were called us-
ing Model-based Analysis of ChIP-Seq with P value 1e-3 com-
pared to the input samples. Common peaks found in the trip-
licates were selected. Furthermore, ChIP peaks located in re-
peat sequences and rDNA were removed. Sequence motifs en-
riched within 70 bp of peak summits were identified using
MEME-ChIP.
Whole genome bisulfite sequencing library preparation
and sequencing
Genomic DNA was fragmented by sonication to a mean size of
250 bp using a Bioruptor (Diagenode, Belgium), followed by the
blunt-ending, dA addition to 3′-end, and adaptor ligation using
the TruSeq Sample Preparation kit (Illumina Inc.) according to
the manufacturer’s instructions. Then, bisulfite conversion was
conducted with the EZ DNA Methylation-Gold kit (ZYMO). The
fragments with different insert size were excised from the same
lane of a 2% (Tris-Acetate-EDTA) agarose gel. Products were puri-
fied using the QIAquick Gel Extraction kit (Qiagen) and amplified
by 18 PCR cycles. The library quality was monitored using the
Agilent 2100 BioAnalyzer (Agilent), and the concentration of the
library was determined by quantitative PCR. Finally, the whole
genome bisulfite sequencing (WGBS) libraries were paired-end
sequenced on Illumina HiSeq X Ten.
After filtering out adaptor and low-quality reads, 953.7 Gb
150 bp paired-end clean data were generated. An average of
106 Gb clean data were obtained for each sample. Clean reads
were aligned to the human reference genome (hg19) by BSMAP
(v2.74) with the parameter “-u -v 5 -z 33 -p 6 -n 0 -w 20 -s 16
-r 0 -f 10 -L 140” [23]. Only the CpG sites with read depths ≥4
were taken into consideration for DNA methylation level calcu-
lation. The 48 502 bp lambda DNA genome was used as an ex-
tra reference for calculating the bisulfite conversion rate. Nearly
complete (>99%) bisulfite conversion was documented in all li-
braries. For the repeat WGBS experiment, HEK293T cells were
transfected with pUC19 as controls or transfected with dCas9-
BFP-DNMT3A and uPA gRNAs. Transfections were conducted in
triplicates. Genomic DNAwas purified from all cells 48 hours af-
ter transfection without BFP-based FACS enrichment of trans-
fected cells. WGBS library construction and sequencing were
conducted as above but sequenced with less depth of 10–15X
coverage.
Identification of DMRs and attempts to exclude
stochastic DMRs unrelated to the dCas9
methyltransferase treatment
The bioconductor package DSS was used to identify DMRs with
the parameter “delta > = 0.1, P value ≤ 0.01, CpG sites ≥ 3, DMR
length ≥ 10 bp, smoothing window 100 bp.” Since expressing a
high amount of dCas9-BFP-DNMT3A and either uPA or TGFBR3
gRNAs caused the highest de novo on-targetmethylation, we rea-
soned that the authentic off-target DMRs should be detected
in these 2 comparisons. We first compared group 1 (dCas9-BFP-
DNMT3A [500 ng] + uPA gRNAs [500 ng]) or group 3 (dCas9-BFP-
DNMT3A [500 ng] + TGFBR3 gRNAs [500 ng]) to group 9 (pUC19
control).
Based on the observation of (1) dose- and gRNA-dependent de
novo methylation of uPA, TGFBR3, and GAPDH by dCas9 methyl-
transferases and (2) dCas9-BGP-DNMT3A being more efficient
than dCas9-BFP-DNMT3B, we reasoned that the authentic DMRs
caused by dCas9methyltransferases and uPA gRNAs should have
a methylation pattern as described below:
Hypermethylated DMRs by dCas9 methyltransferases and
uPA gRNAs should meet:
% mCpG:
(1) group 9 (pUC19) = < group 5 (dCas9-DNMT-3A only [500 ng])
= < group 7 (dCas9-DNMT-3A [50 ng] + uPA gRNAs [50 ng]) =
< group 1 (dCas9-DNMT-3A [500 ng] + uPA gRNAs [500 ng]).
(2) group 2 (dCas9-DNMT-3B [500 ng] + uPA gRNAs [500 ng]) =
< group 1 (dCas9-DNMT-3A [500 ng] + uPA gRNAs [500 ng])
(3) group 6 (dCas9-DNMT-3B [500 ng]) = < group 2 (dCas9-
DNMT-3B [500 ng] + uPA gRNAs [500 ng])
Hypomethylated DMRs by dCas9 methyltransferases and
uPA gRNAs should meet:
% mCpG:
(1) group 9 (pUC19) > = group 5 (dCas9-DNMT-3A only [500 ng])
> = group 7 (dCas9-DNMT-3A [50 ng] + uPA gRNAs [50 ng]) >
= group 1 (dCas9-DNMT-3A [500 ng] + uPA gRNAs [500 ng]).
(2) group 2 (dCas9-DNMT-3B [500 ng] + uPA gRNAs [500 ng]) >
= group 1 (dCas9-DNMT-3A [500 ng] + uPA gRNAs [500 ng])
(3) group 6 (dCas9-DNMT-3B [500 ng]) > = group 2 (dCas9-
DNMT-3B [500 ng] + uPA gRNAs [500 ng])
Similarly, the authentic DMRs caused by dCas9 methyltrans-
ferases and TGFBR3 gRNAs should have amethylation pattern as
described below:
Hypermethylated DMRs by dCas9 methyltransferases and
TGFBR3 gRNAs should meet:
% mCpG:
(1) group 9 (pUC19) = < group 5 (dCas9-DNMT-3A only [500
ng]) = < group 8 (dCas9-DNMT-3A [50 ng] + TGFBR3 gRNAs
[50 ng]) = < group 3 (dCas9-DNMT-3A [500 ng] + TGFBR3 gR-
NAs [500 ng]).
(2) group 4 (dCas9-DNMT-3B [500 ng] + TGFBR3 gRNAs [500 ng])
= < group 3 (dCas9-DNMT-3A [500 ng] + TGFBR3 gRNAs
[500 ng])
(3) group 6 (dCas9-DNMT-3B [500 ng]) = < group 4 (dCas9-
DNMT-3B [500 ng] + TGFBR3 gRNAs [500 ng])
Hypomethylated DMRs by dCas9 methyltransferases and
TGFBR3 gRNAs should meet:
% mCpG:
(1) group 9 (pUC19) > = group 5 (dCas9-DNMT-3A only [500
ng]) > = group 8 (dCas9-DNMT-3A [50 ng] + TGFBR3 gRNAs
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[50 ng]) > = group 3 (dCas9-DNMT-3A [500 ng] + TGFBR3 gR-
NAs [500 ng]).
(2) group 4 (dCas9-DNMT-3B [500 ng] + TGFBR3 gRNAs
[500 ng]) > = group 3 (dCas9-DNMT-3A [500 ng] + TGFBR3
gRNAs [500 ng])
(3) group 6 (dCas9-DNMT-3B [500 ng]) > = group 4 (dCas9-
DNMT-3B [500 ng] + TGFBR3 gRNAs [500 ng])
We applied this methylation level-based filtering criteria to
further remove potential stochastic DMRs. The remaining DMRs
were subjected to all analyses as described in this study.
Analysis of 5nt-SEED-NGG motif density
The 5nt-SEED-NGG density was calculated by counting the fre-
quency of the sequence containing the 5nt SEED sequences pre-
ceding a NGG site on either DNA strand. The PAM density was
calculated by counting the frequency of PAM sites (NGG) on ei-
ther DNA strand. Themedian density with standard deviation is
shown in the plots. Fisher exact test was conducted to compare
densities between different sequence datasets.
Statistics
All values in this study were presented as mean ± standard de-
viation. The 1-way analysis of variance (ANOVA) with Bonfer-
ronimultiple testing, linear regression,Wilcoxonmatched-pairs
signed-rank test, Fisher exact test, and Benjamini-Hochberg–
adjusted P value were used for statistical analysis. A P value <
0.05 was considered statistically significant.
Results
On-target DNA methylation by dCas9
methyltransferases: dCas9-BFP-DNMT3A and
dCas9-BFP-DNMT3B
In mammalian cells, DNA methylation is established by de novo
DNA methyltransferases (DNMT3A and DNMT3B) and main-
tained upon replication by DNMT1 [24]. Using a similar approach
as Vojta et al. [15] and McDonald et al. [16], we fused DNMT1
catalytic domain, DNMT3A catalytic domain, DNMT3B catalytic
domain, or EGFP to the C-terminal end of dCas9 with a blue
fluorescent protein (BFP) and a triple tandem repeated flexi-
ble linker (3XG4S, Gly-Gly-Gly-Gly-Ser) (Fig. 1a and Supplemen-
tary Fig. S1a). Enrichment of cells expressing the fusion dCas9
methyltransferases were validated by BFP-based fluorescence
activated cell sorting (FACS) (Supplementary Fig. S1b) and im-
munofluorescence staining using anti-HA tag antibody (Supple-
mentary Fig. S1c).
To validate that dCas9methyltransferases canmethylate en-
dogenous CpGs, the dCas9 methyltransferases were first tar-
geted by 5 gRNAs (uPA gRNA T1 to T5, Fig. 1b) to the uPA
promoter, which contains a dense CpG island (CGI) that is hy-
pomethylated in human cancer cells [25]. HEK293T cells were
transfected with uPA gRNAs and individual dCas9 fusion expres-
sion vectors. Following BFP-based FACS enrichment of trans-
fected cells, the percentage of methylated CpGs (mCpGs) at in-
dividual CpG sites in the uPA promoter (uPA-MR1 and uPA-MR2
genomic regions) was quantified by bisulfite pyrosequencing
(Fig. 1c). Compared to the pUC19 control, cells expressing uPA
gRNAs and dCas9-BFP-DNMT3A or dCas9-BFP-DNMT3B, but not
dCas9-BFP-DNMT1 or dCas9-BFP-EGFP, had significantly higher
mCpG levels (P value < 0.01, ANOVA test). This is consistent with
previous reports showing that the C-terminal catalytic domains
of DNMT3A and DNMT3B, but not DNMT1, are active [26, 27].
The CpGs most efficiently de novo methylated were located 10–
50 bp upstream and downstream of the gRNA target sites. CpGs
located in the gRNA binding sites were not methylated by the
dCas9 methyltransferases, most likely because CRISPR/dCas9
binding blocks the interaction of the methyltransferase domain
with the CpGs (Fig. 1c). De novo methylation by dCas9-BFP-
DNMT3A and gRNAs was further validated by bisulfite Sanger
sequencing (Supplementary Fig. S1d).
To investigate dCas9 methyltransferase-mediated methyla-
tion of another genomic locus, we generated 3 gRNAs targeting
the transforming growth factor beta receptor 3 (TGFBR3) pro-
moter. Similar de novo methylation effects were observed for
dCas9-BFP-DNMT3A or dCas9-BFP-DNMT3B with TGFBR3 gRNAs
(Fig. 1d–g; Supplementary Fig. S2). Our results collectively reveal
that fusion of dCas9 to the catalytic domain of DNMT3A/3B can
mediate targeted de novo DNA methylation.
Off-target methylation by dCas9 methyltransferases
Since high-frequency off-target mutagenesis has been observed
in previous applications of CRISPR-Cas9 [28], we investigated the
specificity of dCas9 methyltransferases. For this purpose, we re-
peated the experiment with 2 additional controls: (1) cells ex-
pressing dCas9-BFP-DNMT3A or dCas9-BFP-DNMT3B only and
(2) cells expressing dCas9-BFP-DNMT3A or dCas9-BFP-DNMT3B
and 3 scrambled gRNAs (gRNAs targeting the CMVpromoter).We
found that expression of dCas9 methyltransferases and scram-
bled gRNAs could cause some unspecific de novo methylation
of the uPA promoter, but at much lower levels compared to
that obtained for uPA gRNAs (Supplementary Fig. S3). A slightly
increased uPA promoter methylation, although not significant,
was also observed in cells expressing dCas9 methyltransferase
only (Supplementary Fig. S3).
To further assess the off-target methylation, we investigated
3 genomic regions with various sequence similarities to the
uPA gRNA target sites: SH2D3C (3 mismatches, Supplementary
Fig. S4a), FAM221A (3 mismatches, Supplementary Fig. S4b),
and GAPDH promoter (9 mismatches, Fig. 2a). We did not ob-
serve significant changes in CpG methylation at SH2D3C and
FAM221A genomic sites. Surprisingly, several CpG sites in the
GAPDH promoter were significantly methylated in cells express-
ing dCas9-BFP-DNMT3A and uPA, TGFBR3, or scrambled (CMV)
gRNAs (Fig. 2b–c). The same was observed, but to a lesser ex-
tent, in cells expressing dCas9-BFP-DNMT3B (Fig. 2d–e). This
effect was less prominent in cells expressing dCas9 methyl-
transferase only, indicating that unspecific methylation of the
GAPDH promoter is RNA guided. Our results collectively reveal
the existence of site-dependent off-target methylation by dCas9
methyltransferases.
Effects of DNMT3A/3B catalytic activity and dCas9
methyltransferase expression level on on-target and
off-target DNA methylation
De novo methylation by dCas9 methyltransferases could be me-
diated either by the catalytic activity of DNMT3A and DNMT3B
or by the recruitment of additional DNAmethylation enzymes to
the binding sites facilitated by protein interactions. To elucidate
the mechanism of on-target and off-target DNA methylation,
we introduced the E752A and E697A catalytically inactivating
mutations [29] in the DNMT3A and DNMT3B catalytic do-
mains, respectively. To investigate the effect of dCas9 methyl-
transferase expression levels on on-target and off-target DNA
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Figure 1: De novo uPA and TGFBR3methylation by RNA-guided dCas9 methyltransferases. (a) Schematic illustration of the dCas9 methyltransferase expression vectors.
PGK: phosphoglycerate kinase promoter; G4S: GGGGS linker; NLS: nuclear localization signal; U6: human U6 promoter. (b) Schematic illustration of the uPA promoter
and gRNA target sites (T1–T5), 2 uPA methylated regions (uPA-MR1, uPA-MR2), and CpGs analyzed by bisulfite pyrosequencing. TSS: transcription start site. Numbers
indicate distances in base pairs from TSS. (c) Line plots of the percentage of methylated CpGs (mCpG). Red line: the BFP positive cells (BFPp). Light blue line: BFP
negative cells (BFPn). Note that %mCpG in control cells transfected with pUC19 has been replotted as a reference (black line). BFPn cells include cells expressing a very
low level of dCas9 methyltransferase. Each data point represents mean ± SD (n = 2–4). Asterisk (∗) indicates statistical significance (P < 0.05) compared to the control
after Bonferroni correction. (d) Schematic illustration of the human TGFBR3 promoter locus, TGFBR3 gRNA binding sites (red arrows), potential off-target binding sites
(black horizontal arrows) of the scrambled gRNA, and CpG sites. (e) Line plots of % mCpG at the TGFBR3 promoter in cells expressing dCas9 methyltransferase with
(red line) or without (green line) TGFBR3 gRNAs, or with the scrambled gRNAs (gray line). Note that %mCpG in control cells transfected with pUC19 has been replotted
as a reference (black line). Each data point represents mean ± SD (n = 2–5). (f and g) Bar chart of average methylation levels for TGFBR3-MR1 (f) and TGFBR3-MR2 (g)
CpG sites. Values represent mean ± SD (n = 3). Asterisk (∗) represents P value < 0.05 compared to pUC19 (ANOVA).
Downloaded from https://academic.oup.com/gigascience/article-abstract/7/3/giy011/4875932
by Det Kongelige Bibliotek user
on 17 July 2018
Genome-wide profiling of off-target methylation by dCas9 methyltransferases 7
Figure 2: Off-target methylation of GAPDH promoter by dCas9 methyltransferases and gRNAs. (a) Schematic illustration of the GAPDH promoter. Potential off-target
sites and CpGs analyzed by bisulfite pyrosequencing are indicated. Sequences of potential off-target binding sites by uPA, TGFBR3, and scrambled gRNAswithmaximum
10 mismatches are listed. (b–d) Line plots of GAPDH promoter methylation in FACS-sorted HEK293T cells 48 hours after transfection with dCas9 methyltransferases
and gRNAs. The methylation profiles from the pUC19-transfected samples were replotted as reference. Each data point in the graph represents the mean ± SD (n =
2 independent transfections). Average methylation levels for all CpGs analyzed are presented next to line legends. Asterisks (∗) represent P value < 0.05 compared to
pUC19 (ANOVA).
methylation, cells were sorted into 4 populations based on BFP
signal intensity, a marker of dCas9 methyltransferase expres-
sion level: 1, very low: +; 2, low: ++; 3, medium: +++; and 4,
high: ++++ (Fig. 3a). Bisulfite pyrosequencing analysis of the
uPA (Fig. 3b) and TGFBR3 (Fig. 3c, Supplementary Fig. S5) promot-
ers revealed that only dCas9 methyltransferases, but not dCas9
methyltransferase catalytic mutants, cause dose-dependent de
novomethylation, suggesting that de novo on-target methylation
by dCas9 methyltransferases is mediated by the catalytic activ-
ity of DNMT3A and DNMT3B.
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Figure 3: On-target methylation by dCas9methyltransferases. (a) Schematic illustration of the experiment. dCas9 methyltransferase-expressing cells were enriched by
FACS 48 hours after transfection and sorted according to the BPF signal: +, ++, +++, ++++. Right: Representative FACS plot and gating. (b and c) Bar charts indicating
% mCpG for individual CpG and average values of all CpG sites in the uPA (b) and TGFBR3 (c) target regions. The schematic illustrations above the bar graphs show
gRNA binding sites and CpG sites analyzed. Value represents mean ± SD (n = 3). Asterisk (∗) indicates statistical significance (P < 0.05, ANOVA) compared to the control
after Bonferroni correction. Figure legend for bar graphs in (b) and (c) is presented at bottom right.
Next, we investigated the effect of dCas9 methyltransferase
expression level on off-target methylation by analyzing the
GAPDH promoter methylation in the FACS-sorted cells with dif-
ferent BFP signal intensity (+, ++, +++, and ++++). Consistent
with previous results, co-expression of dCas9-BFP-DNMT3A or
dCas9-BFP-DNMT3B (Fig. 4a, b) with either uPA or TGFBR3 gRNAs
significantly increased de novo methylation of GAPDH promoter
CpGs compared to cells expressing dCas9 methyltransferase
without gRNAs or pUC19. Furthermore, titrating dCas9 methyl-
transferase expression levels decreased unspecific methylation
of the GAPDH promoter (Fig. 4a, b). Similarly, methyltransferase
catalytic mutants do not cause de novo methylation of GAPDH.
Since de novo methylation of gRNA-targeted genes was also de-
creased by dCas9 methyltransferase titration (Fig. 3), our results
collectively suggest that altering dCas9 methyltransferase ex-
pression levels cannot efficiently reduce unspecific methylation
relative to targeted methylation.
To investigate global methylation levels, repetitive LINE1 el-
ements were investigated as they represent a surrogate marker
for global DNA methylation [30]. We measured the LINE1 5′UTR
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Figure 4: Off-target methylation by dCas9 methyltransferases. (a) Bar charts indicating % mCpG at individual CpGs and total % mCpG (8 CpG sites) for the GAPDH
promoter in cells expressing different levels (BFP signal: +, ++, +++, ++++) of dCas9-BFP-DNMT3A or dCas9-BFP-DNMT3A(E752A) alone or together with either uPA
or TGFBR3 gRNAs. (b) Bar charts indicating %mCpG in the GAPDH promoter in cells expressing different levels (BFP signal:+,++,+++,++++) of dCas9-BFP-DNMT3B or
dCas9-BFP-DNMT3B(E697A) alone or with TGFBR3 gRNAs. (c) LINE1 5′UTRmethylation in cells expressing uPA gRNAs with different levels of either dCas9-BFP-DNMT3A
or dCas9-BFP-DNMT3A(E752A). Cells transfected with pUC19 were used as controls. Values represent mean ± SD (n = 3). Asterisks (∗) represent P value < 0.05 (ANOVA)
compared to pUC19.
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Figure 5: De novomethylation of uPA, TGFBR3, and GAPDH promoters by dCas9methyltransferasemeasured withWGBS. Dot plots of %mCpG for individual CpG sites in
the uPA, TGFBR3, and GAPDH promoter regions. Each dot represents 1 CpG site. Right panel indicates the transfected plasmids. mCpG levels were quantified by WGBS.
Scale bar, 200 bp.
methylation by bisulfite pyrosequencing, which revealed that
expression of dCas9-BFP-DNMT3A and uPA gRNAs did not result
in significant LINE1 methylation changes (Fig. 4c).
Genome-wide bisulfite sequencing revealed off-target
methylation by dCas9 methyltransferases
Prompted by the unspecific methylation of GAPDH promoter
by dCas9 methyltransferases, we investigated the genome-wide
off-target methylation characteristics by CRISPR dCas9 methyl-
transferases using WGBS. WGBS was conducted in HEK293T
cells transfectedwith (i) pUC19 (control), (ii) dCas9-BFP-DNMT3A
or dCas9-BFP-DNMT3B alone, and (iii) dCas9-BFP-DNMT3A or
dCas9-BFP-DNMT3Bwith either uPA or TGFBR3 gRNAswith 2 dif-
ferent doses (50 ng or 500 ng) (Supplementary Fig. S6a). Using the
Illumina HiSeq X platform, we generated more than 100 Gb of
clean data for each sample (more than 30× coveragewith a 99.5%
bisulfite conversion rate). This allowed us to analyze the methy-
lation pattern at single base-pair resolution. Since mainly CpG
dinucleotides are subject to methylation in HEK293T cells (Sup-
plementary Fig. S6b), all following analyses are based on CpG
methylation in the entire genome (approximately 40 000 000 CpG
sites). First, we examined uPA, TGFBR3, and GAPDH promoter
methylation as revealed by WGBS in all 9 groups. WGBS con-
firmed that the uPA and TGFBR3 gRNAs could target dCas9-BFP-
DNMT3A or dCas9-BFP-DNMT3B to the uPA and TGFBR3 loci and
methylate CpGs flanking the gRNA binding sites in a dose- and
gRNA-dependent manner (Fig. 5). Furthermore, our WGBS data
revealed that some dCas9 methyltransferase-mediated de novo
methylation of uPA, TGFBR3, and GAPDH (off-target) promoters
occurred in a broad region surrounding the gRNA binding site.
Next, we analyzed the global DNA methylation profile. Con-
sistent with the LINE1 assay (Fig. 3c), expression of dCas9
methyltransferase alone or together with gRNAs was not
associated with global methylation changes (Supplementary
Fig. S6c, d). Sincewe have only 1 replicate per group and stochas-
tic methylations frequently occur in cancer cells during culti-
vation [31], we analyzed the data with DSS-single (a method
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developed byWu et al. for detecting DMRs fromWGBS datawith-
out replicates [32]) to identify DMRs caused by dCas9 methyl-
transferase and gRNAs. We compared cells transfected with
dCas9methyltransferaseswith orwithout gRNAs to control cells
(transfected with pUC19 control plasmid). More than10 000 hy-
per or hypo DMRs were identified by DSS-single (Supplemen-
tary Fig. S7). Next, based on the observation that (1) there is
dose- and gRNA-dependency of uPA, TGFBR3, andGAPDHmethy-
lation by dCas9methyltransferase and (2) dCas9-BFP-DNMT3A is
more efficient than dCas9-BFP-DNMT3B, we applied a stringent
filtering step to remove potentially stochastic DMRs. Following
this filtering, we identified more than 1000 DMRs resulting from
dCas9methyltransferase togetherwith either uPA gRNAs (hyper-
methylated DMRs [hyper-DMRs] = 3671; hypomethylated DMRs
[hypo-DMRs] = 1807) or TGFBR3 gRNAs (hyper-DMRs = 2267;
hypo-DMRs = 1662) (Supplementary Tables S2–S5). These DMRs
were on average 63–81 bp and contained an average of 5–9 CpGs
(Supplementary Fig. S8). The averagemethylation levels of these
hyper-/hypo-DMRs differ significantly between pUC19 control
cells, cells expressing dCas9 methyltransferase only, cells ex-
pressing low amounts of dCas9 methyltransferase and gRNAs,
and cells expressing high amounts of dCas9 methyltransferase
and gRNAs (Fig. 6a, Supplementary Fig. S9a). Only a very small
portion of the DMRs (hyper-DMRs = 192; hypo-DMRs = 81) were
commonly found among DMRs caused by dCas9 methyltrans-
ferase and uPA compared to TGFBR3 gRNAs (Fig. 6b), suggesting
that the majority of the off-target DMRs are RNA guided. Taken
together, our WGBS result revealed that expression of dCas9
methyltransferases together with gRNAs can cause substantial
off-target methylation.
Characteristics of dCas9 methyltransferase off-targets
To better describe the characteristics of dCas9 methyltrans-
ferase off-targets, we stratified hyper- and hypo-DMRs accord-
ing to their localization in particular types of genomic regions,
including promoters, coding sequences, introns, 5′ untranslated
regions (5-UTR), 3-UTR, CGIs, CGI shores, Alu sequences, LINE1
(L1) sequences, and LINE2 (L2) sequences. Our results showed
that hyper-DMRs were predominantly enriched in promoters, 5-
UTR, and CGIs, whereas hypo-DMRs were enriched in repeated
sequences Alu and LINE1 (Fig. 6c–d, Supplementary Fig. S9b–
c). Consistent with this finding, a metaplot of average methy-
lation levels for all genes before the DSS-single call also showed
that transcription start site flanking regions (overlapping with
promoters and 5′UTR) were hypermethylated in cells expressing
dCas9 methyltransferase and gRNAs (Supplementary Fig. S10).
Since dCas9 preferentially binds open chromatin regions [33],
we further analyzed DNase I hypersensitivity regions based
on ENCODE data from HEK293T cells (GEO#: GSM1008573) and
quantified the average methylation level in DNase I hypersensi-
tivity sites (DHS) (as an indication of sites with an open chro-
matin state). The DHS flanking regions (1 kb upstream and
downstream) were used as a control. Compared to cells trans-
fected with pUC19, cells expressing dCas9 methyltransferase
and gRNAs had significantly higher methylation levels in the
DHS sites (P value < 0.05; Wilcoxon matched-pairs signed-rank
test) (Fig. 6e, Supplementary Fig. S9d). Furthermore, only hyper-
DMRs, but not hypo-DMRs, were significantly enriched in DHS
(P value < 1e-300, Fisher exact test, Fig. 6f–g and Supplemen-
tary Fig. S9e–f), which collectively suggests that open chromatin
regions are prone to unspecific methylation by dCas9 methyl-
transferase and gRNAs.
Previous studies have discovered that complementary base
pairing between gRNA guide sequences and the PAM-proximal
5nt region (5ntSEED-PAM) is crucial for off-target binding [33, 34].
We also assessed the density of individual gRNA 5ntSEED-PAM
sequence (5′-NNNNNNGG-3′) in the hyper- and hypo-DMRs. For
each DMR,we included the 100-bp flanking sequenceswhen cal-
culating the presence of 5ntSEED-PAM sequence density. This
is based on the previous observation that dCas9 methyltrans-
ferases methylate CpGs flanking the gRNA binding site. We con-
sistently observed significant enrichment of 5ntSEED-PAM se-
quences for all gRNAs in the hyper-DMRs, but not hypo-DMRs
(Fig. 6h, Supplementary Fig. S9g). Taken together, this shows
that if guided by gRNAs, dCas9 methyltransferases can cause
substantial off-target methylation of genomic regions with open
chromatin accessibility, i.e., promoters and 5′UTR, aswell as CGI.
Our finding between the off-target methylation and the chro-
matin accessibility is also consistent with our recent discovery
that CRISPR/Cas9 cleaves more efficiently in euchromatin than
heterochromatin regions [35].
dCas9 methyltransferase-mediated hypermethylated
DMRs are weakly correlated with off-target binding
To further investigate the association between dCas9 methyl-
transferase off-target methylation and dCas9 off-target DNA
binding, we studied off-target binding sites in HEK293T cells
expressing dCas9 methyltransferase and uPA gRNAs using
ChIP-seq. Using pair-wise comparison as the previous ap-
proach for dCas9 [34], 805 enriched peaks (P value < 0.001,
Supplementary Table S6) were identified. These ChIP peaks
were scattered throughout the genome and significantly en-
riched in DHS genomic regions (Fig. 7a, b). Using MEME
motif scanning of ChIP peaks [36], we identified the most
significant motif GGGAGAGGGAGNGG (P = 1.0e-593). This mo-
tif is identical to the 11-bp seed sequences of uPA gRNA T2
(GAGCCGGGCGGGAGAGGGAG(GGG)) and the PAM (NGG) site
(Fig. 7c), suggesting that T2 is dominant compared to other uPA
gRNAs inmediating off-target binding. Analysis of 5ntSEED-PAM
sequence density further confirmed that uPA T2 binding sites
were overrepresented in the ChIP peaks (Fig. 7d). A previous
study has shown that the choice of gRNAs has a great effect on
dCas9 off-target binding [34]. The uPA gRNA T2 is highly G-rich
or AG-rich in the seed region. This can potentially be the cause of
most of the off-target activities. This could be the explanation of
why we have found 40 times more off-target binding sites com-
pared to those reported in the study by Liu et al. [37].
Next, we analyzed the correlation between the ChIP peaks
and the uPA DMRs (including the flanking 100 bp of each DMR).
There is a significantly increased overlap between ChIP peaks
and uPA hyper-DMRs (P = 0.006, Fisher exact test), but not uPA
hypo-DMRs (P = 1, Fisher exact test) (Fig. 7e). However, the per-
centage of uPA hyper-DMRs overlaps with ChIP peaks is still very
low (11 of 3671 hyper-DMRs, 0.3%). Since the average methyla-
tion level of all ChIP peak regions exceeds 60% (Supplementary
Fig. S11), thismay partially explainwhy there is a low correlation
between ChIP peaks and DMRs given potential functional diffi-
culty in further increasing the methylation level. Furthermore,
ChIP-seq only identified sites to which the dCas9 methyltrans-
ferase binds strongly.
Effects of dCas9 methyltransferases on gene expression
Methylation of promoter DNA can be correlated with inhibi-
tion of gene transcription. To determine whether the dCas9
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Figure 6: Genomic characteristics of off-target DMRs caused by dCas9 methyltransferases and uPA gRNAs. (a) Box plot (top) and heat map clustering (bottom) of the
hypermethylated (left) and hypomethylated (right) DMRs resulting from dCas9 methyltransferases and uPA gRNAs. (b) Venn diagram presentation of hypermethylated
(top) or hypomethylated (bottom) DMRs caused by dCas9methyltransferases and uPA gRNAs compared to TGFBR3 gRNAs. (c and d) Bar chart illustrating the percentage
of the identified uPA hypermethylated (c) or hypomethylated (d) DMRs that fall into the different types of genomic regions indicated. Background represents a random
sample of the same number of similar sized genomic windows that fall into the categories indicated. Values above bars are P values between background and uPA-
DMRs (Fisher exact test). (e) Metaplot of average CpG methylation levels in 58 494 DNase I hypersensitive sites (DHS) and 1 kb upstream and downstream flanking
regions. (f and g) Bar chart of % uPA hypermethylated (f) or hypomethylated (g) DMRs falling into DHS core regions. (h) Density of 5nt-SEED-NGG for uPA gRNAs (T1 to
T5) in background genomic windows and uPA DMRs + flanking 100 bp. Values represent median density with 1 standard deviation. P values (t test) are given above the
bar charts.
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Figure 7: Correlation between dCas9-BFP-DNMT3A off-target binding and off-target methylation. (a) Bar chart illustrating the percentage of ChIP peaks from cells
expressing dCas9-BFP-DNMT3A and uPA gRNAs or background control regions (random sampling of the same number of similar sized genomic windows as the ChIP
peaks) falling into the different types of genomic regions indicated. P values between background and ChIP peaks indicated above bars, Fisher exact test. (b) Bar chart
of % ChIP peaks falling into DHS core regions. (c) Representative plot of ChIP-seq reads in the uPA promoter, uPA gRNA T2 sequences, and the top motif identified
by MEME-ChIP. (d) Density of 5nt-SEED-NGG for uPA gRNAs (T1 to T5) ChIP peaks. Background is a random sample of the same number of similar sized genomic
windows as ChIP peaks. Values represent median density with 1 standard deviation. P values are given for the indicated comparisons (t test). (e) Bar plot of % ChIP
peaks overlapping with hypermethylated DMRs caused by dCas9 methyltransferase and uPA gRNAs. Background is a random sample of the same number of similar
sized genomic windows as DMRs.
methyltransferase-mediated uPA and TGFBR3 promoter methy-
lation could inhibit gene expression, we measured uPA and
TGFBR3 mRNA levels by qPCR in HEK293T cells. Compared to
the pUC19 transfection control, both uPA and TGFBR3 expres-
sions were significantly decreased in cells expressing dCas9-
BFP-DNMT3A or dCas9-BFP-DNMT3B and either uPA or TGFBR3
gRNAs (Fig. 8a). However, the reduced uPA and TGFBR3 ex-
pression does not appear to be only associated with the de
novo DNA methylation by dCas9 methyltransferases (Fig. 8a),
as inactivating dCas9 methyltransferase mutants dCas9-BFP-
DNMT3A(E752A) and dCas9-BFP-DNMT3B(E697A) also cause
similar degrees of expression inhibition despite their lack of de
novo DNA methylation activity.
To investigate whether the inhibition of gene expression is
specific to the gRNA targeted genes,we conducted RNA sequenc-
ing in HEK293T cells expressing dCas9 methyltransferase and
uPA gRNAs. A large number (>1000) of differentially expressed
genes (DEGs) significantly (FDR P value < 0.001, fold change >2)
were found in cells expressing uPA gRNAs and either dCas9-BFP-
DNMT3A or dCas9-BFP-DNMT3B (Fig. 8b–c). However, similar
effects on the global transcription profile were observed in cells
expressing uPA gRNAs with dCas9-BFP-DNMT1 or with dCas9-
BFP-EGFP lacking de novo DNA methylation activity (Fig. 8d-e).
We cross-compared DEGs among the 4 groups, and 342 (18%–
32%) genes were commonly identified (Fig. 8f). For DEGs found
in cells expressing dCas9-BFP-DNMT3A and uPA gRNAs, we also
performed integrative analyses of the expression change, pro-
moter methylation, and promoter binding intensity (Fig. 8g).
Very weak but significant correlation was identified for a few
clusters of DEGs. Taken together, these results suggest that the
nonspecific alteration of transcription is not merely caused by
promoter methylation or binding of dCas9 methyltransferase.
Since uPA is an important factor in regulating cell prolifera-
tion and inhibition of cell growth was found in cells expressing
dCas9 methyltransferases and uPA gRNAs (Supplementary Fig.
S12), the large number of differentially expressed genes might
be a result of altered cellular functions. Taken together, our re-
sults clearly indicate that inhibition of uPA and TGFBR3 expres-
sion by dCas9 methyltransferase and corresponding gRNAs is
not merely due to de novo DNA methylation of their promoters.
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Figure 8: Effect of dCas9methyltransferases on gene expression. (a) Relative gene expression levels of uPA and TGFBR3 in cells expressing different levels of dCas9-BFP-
DNMT3A, dCas9-BFP-DNMT3B, dCas9-BFP-DNMT3A(E752A), or dCas9-BFP-DNMT3B(E697A). mRNA expression was measured by qPCR and quantified as fold change
compared to control cells transfected with pUC19. Bar charts depict mean change in mRNA level compared to pUC19 controls. Data represent mean ± SD (n = 3
independent transfections). Mean percentage decrease in mRNA level compared to pUC19 is presented on top of bars. Asterisks (∗) represent P value < 0.05 compared
to pUC19. (b–e) Dot plots of log10 (TPM) for all genes expressed in the BFP positive (BFPp) cells expressing uPA gRNAs (T1-T5) and dCas9-BFP-DNMT3A (b), dCas9-
BFP-DNMT3B (c), dCas9-BFP-DNMT1 (d), or dCas9-BFP-EGFP (e) plotted against log10 (TPM) in a pUC19 control group. DEGs are marked in red (upregulated) and green
(downregulated) (fold change ≥2, FDR < 0.001). Fold changes compared to pUC19 and FDR P values for DNMT1, DNMT3A, DNMT3B, EGFP, and uPA are shown. (f) Venn
diagram representation of cross-comparison of DEGs. (g) Integrative analysis of gene expression change, promoter methylation, and promoter binding caused by
dCas9-BFP-DNMT3A and uPA gRNAs for the different clusters of DEGs. Heat map represents linear regression P values. Dot plots were given for significant correlations
(P < 0.05).
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To determinewhether longer-term inhibition of gene expres-
sion can be facilitated by dCas9 methyltransferases, 5 HEK293T
fluorescent reporter cell clones carrying different copies of a
CMV-mCherry expression cassette (Supplementary Fig. S13a,
b) were generated. We quantified mCherry level by FACS for
2 weeks after transfection. We observed that the number of
dCas9 methyltransferase-expressing cells peaked on day 2 and
decreased gradually (Supplementary Fig. S13c). Maximal inhi-
bition of mCherry levels were observed on day 5 after trans-
fection (Supplementary Fig. S13d-h). Compared to other dCas9
fusion proteins, the dCas-BFP-DNMT3A fusion resulted in the
highest and longest inhibition of mCherry expression in the re-
porter cells (4 of 5 clones) (Supplementary Fig. S13d–h). The tran-
sient and prolonged inhibition efficacy varied among the 5 cell
clones. For example, clone 2, which has the lowest copy number
of transgene, showed the highest transient and longest inhibi-
tion by dCas-BFP-DNMT3A (Supplementary Fig. S13e). However,
expression of mCherry was, in all clones, not significantly dif-
ferent from the pUC19 control after 2 weeks, suggesting that in-
hibition of gene expression by dCas9 methyltransferases is not
stably maintained.
Discussion
Since dCas9 methyltransferases are targeted to a specific ge-
nomic locus simply by a small gRNA, this system is more con-
venient than ZF- or TALE-based methyltransferases [29, 38, 39].
Recently, Vojta et al. [15] and McDonald et al. [16] reported that
directly fusing DNMT3A to dCas9 could be used to induce DNA
methylation at specific loci in HEK293T cells. Consistent with
that, we show that dCas9-BFP-DNMT3A can methylate CpGs
flanking the gRNA binding sites in genomic loci, further prov-
ing the general applicability of dCas9 methyltransferases for
targeted DNA methylation in mammalian cells. In addition,
our study shows for the first time that the fusion of dCas9
to DNMT3B is also capable of inducing specific DNA methy-
lation, although the efficiency is lower than that of DNMT3A.
Additionally, Stepper et al. showed that the dCas9-DNMT3A-
DNMT3L fusion can further improve de novo methylation effi-
ciency compared to dCas9-DNMT3A [40]. Together with the re-
ported systems, the dCas9 methyltransferases system reported
in this study further broadens the availability and applicability
of CRISPR-based reprogramming of DNA methylation. Based on
the observation that dCas9 methyltransferases can efficiently
methylate the flanking CpG sites from the gRNA binding site,
we have developed an open-source web-based gRNA designing
tool for dCas9 methyltransferase gRNAs [18].
On the basis of extensive gene-specific bisulfite pyrosequenc-
ing and WGBS, we identified novel off-target methylation char-
acteristics that appear to be predominantly enriched in pro-
moter, 5′UTR, CGI, and open chromatin regions. Since most of
these genomic regions are hypomethylated in HEK293T cells,
it was expected that the off-target DMRs would be enriched
in such regions. In other genomic regions, which already have
a high level of methylation, a further methylation by dCas9
methyltransferase is not achievable. We discovered that open
chromatin regions are highly prone to off-target methylation
by dCas9-methyltransferase. The location of the GAPDH pro-
moter in a DHS region explains why this region is subjected
to highly off-target methylation. To further confirm our finding,
we repeated the WGBS experiment in triplicates (Supplemen-
tary Fig. S14). Our result confirmed that the hyper-methylated
DMRs identified in a previous WGBS experiment (Fig. 6a) are
significantly increased in cells overexpressing dCas9-BFP-
DNMT3A and uPA in the repeated experiments (Supplementary
Fig. S14a). Consistently, DHS regions were significantly methy-
lated in cells expressing dCas9-BFP-DNMT3A and uPA (Supple-
mentary Fig. S14b).
Our study also revealed the gRNA dependency of off-target
methylation. This is consistent with the observations of McDon-
ald et al. [16] and Vojta et al. [15]. Additionally, we discovered
that even in the absence of gRNAs, expression of the dCas9-
BFP-DNMT3A or dCas9-BFP-DNMT3B alone can cause some un-
specific DNA methylation. This gRNA-independent off-target
methylation effect is even more pronounced when too many
dCas9methyltransferases, or the DNMT3A catalytic domain, en-
ter the nucleus. For example, increasing dCas9 methyltrans-
ferase expression level, fusing the catalytic domain of DNMT3A
or DNMT3B directly to Cas9 without the BFP linker, or over-
expressing the DNMT3A catalytic domain will cause increased
gRNA-independent off-target methylation (see extended data
and description in Supplementary File 1).
In this study, we found that expressing dCas9 methyl-
transferases and gRNAs could also cause significant demethy-
lation of genomic regions enriched in repeated sequences.
Repeated sequences, which make up more than half of the hu-
man genome, are generally highly methylated, and their dy-
namics, to some extent, are associated with normal develop-
ment and tumorigenesis. A previous study of methylation in
repeated sequences has shown that with increasing age from
adulthood, there is a global decrease in DNA methylation in re-
peated sequences and intergenic genome sequences [41]. We
also observed that expression of dCas9 methyltransferase alone
or together with gRNA can inhibit HEK293T cell growth (Sup-
plementary Fig. S12). The hypomethylated DMRs could poten-
tially the result of inhibited cell proliferation by dCas9 methyl-
transferase and gRNAs. This should be investigated in future
studies.
Improvement of dCas9methyltransferase specificity, tomini-
mize the gRNA-dependent and gRNA-independent off-target ac-
tivity, is crucial for future applications of the technology.McDon-
ald et al. [16] have observed significant reduction in off-target
methylation using DOX inducible dCas9-DNMT3A. Consistent
with these findings, we found that reducing the dCas9 methyl-
transferase and gRNA expression levels, as well as lowering the
dCas9 methyltransferase nuclear entry efficiency (Supplemen-
tary File 1), can reduce off-target methylation. However, this ap-
proach also reduced on-target methylation levels accordingly.
Thus, this may not represent a plausible way of increasing the
specificity of the system. New approaches should be developed
to reduce off-target methylation while maintaining sufficient
on-target methylation efficiencies. The results presented in this
study highlight the importance of inclusion of extensive con-
trols in subsequent experiments, such as catalytically inactive
dCas9 methyltransferase mutants, scrambled gRNAs, and gRNA
free settings. This is necessary for reliable interpretations of cor-
relations between specific DNA methylation events by dCas9
methyltransferase, gene expression regulation, and phenotypic
effects.
Off-target effect is a major concern in CRISPR/Cas9-based
DNA manipulation technologies and applications. Unlike the
original CRISPR/Cas9 technology, of which the endonuclease ac-
tivity of Cas9 depends heavily on the base-pairing between the
guide sequences and the target site (proto-spacer), the deadCas9
(dCas9)-derived CRISPR technologies and applications are more
dependent on the physical interaction between the dCas9/gRNA
complex and the DNA loci and is more tolerant to mismatches.
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The dCas9 in such CRISPR-derived systems is acting as a cargo
protein, bringing whatever proteins/domains to a specific ge-
nomic locus guided by the small gRNA. As demonstrated in Fig. 2
and Supplementary Fig. S4 of this study and several previous
investigations by ChIP-seq [42–44], the criteria of defining off-
target sites (simply based on mismatches) from wild-type Cas9
is not suitable for the dCas9-derived effector proteins, such as
the dCas9 methyltransferases. Although we only evaluated the
dCas9 methyltransferases, we speculate that these off-target ef-
fects are most likely to be the same for other kinds of dCas9-
based effectors.
In this study, we also observed that dCas9 methyltrans-
ferases can efficiently inhibit expression of genes in human
cells. However, the transient inhibition of gene expression could
have resulted from both promoter methylation and blockage of
transcription by dCas9 methyltransferases. A previous study re-
ported that targeted DNA methylation by a zinc finger-based
methyltransferase is not stably maintained [45]. Our time-
course experiments to study the inhibition of gene expression
gradually decreased during in vitro expansion of the transfected
cells. This could be the result of removal of the de novo estab-
lished epigeneticmarks, dilution of the dCas9methyltransferase
expression plasmids, and/or negative selection of the cells ex-
pressing dCas9 methyltransferases. We also realize that DNA
methylation and gene expression analyses were conducted in
cells transiently transfected with dCas9 methyltransferase ex-
pression plasmids, whichmight lead to severe overexpression of
the dCas9 methyltransferases. Thus, future studies could ben-
efit from being conducted in cells stably or conditionally ex-
pressing low copy numbers of dCas9 methyltransferase to mini-
mize off-target methylation. Our study is the first to reveal novel
characteristics of the on-target and off-target DNA methyla-
tion by dCas9 methyltransferases on a genome-wide scale with
single-base resolution and it highlights the need for develop-
ment of CRISPR DNA methylation editing systems with higher
specificity.
Conclusions
The dCas9 methyltransferases presented here, and other dCas9
fusion protein systems described previously [11, 12, 15, 16], pro-
vide useful tools for targeted epigenome editing. Continued im-
provement of the specificities of these systems and combining
tools to enable simultaneous modification of multiple histones
and DNA loci will enable more precise and stable regulation
of gene structure and function. Such CRISPR gRNA-guided pro-
grammable epigenetic modification tools will hopefully have
broad research applications to delineate the association be-
tween specific epigenetic changes, gene-expression regulation,
and phenotypes.
Availability of supporting data
RNA sequencing, WGBS, and ChIP-seq data are available from





Supplementary Fig. S1. Validation of dCas9 methyltransferase
expression and uPA promoter methylation. (a) Schematic
overview of the human DNA methyltransferases (DNMT1,
DNMT3A, and DNMT3B), with the N-terminal regulatory region,
a C-terminal catalytic domain (CD), and the cytosine C5-DNA
methyltransferase motifs highlighted. The first amino acid (a.a)
residue of the C-terminal catalytic domain, which was fused
to the dCas9, is indicated by an arrow. (b) Representative FACS
sorting and re-analysis of HEK293T cells 48 hours after transfec-
tion. Gating for BFP positive (BFPp) and negative (BFPn) cells are
indicated. (c) Laser scanning microscopy of dCas9 methyltrans-
ferase expression in HEK293T cells, 48 hours after transfection.
The BFP signal from the dCas9-BFP-DNMT1 transfected cells was
enhanced since the BFP signal from the dCas9-BFP-DNMT1 fu-
sion was initially weaker compared to that from the other three
fusion proteins. Scale bar: 20 μm. (d) Validation of RNA-guided
uPA methylation (uPA-MR1) by dCas9-BFP-DNMT3A using bisul-
fite Sanger sequencing.
Supplementary Fig. S2. Validation of dCas9
methyltransferase-mediated TGFBR3 methylation in HEK293T
cells by bisulfite Sanger sequencing. TGFBR3 methylation by
dCas9 methyltransferase and gRNAs was validated by bisul-
fite Sanger sequencing. CpG methylation status is indicated
according to the absolute nucleotide position and color-coded
as red, methylated; blue, unmethylated; or white, unknown
methylation state based on the sequencing signal.
Supplementary Fig. S3. Validation of de novo methylation of
uPA by dCas9 methyltransferase and uPA gRNAs. Line plots of
uPA-MR2 methylation in cells transfected with pUC19 (control),
dCas9-BFP-DNMT3A or dCas9-BFP-DNMT3B only, and dCas9-
BFP-DNMT3A or dCas9-BFP-DNMT3B together with either uPA
gRNAs or scrambled gRNAs.
Supplementary Fig. S4. Effect of dCas9 methyltransferases
on two potential off-target sites (SH2D3C and FAM221A). (a-b)
Schematic illustration of the SH2D3C (b) and FAM221A (c) off-
target loci, with off-target sites indicated by red arrows. Se-
quences of uPA gRNA (T2), SH2D3C, and FAM221A off-target sites
are given above, with the PAM (red letters) and mismatches
(green letters) indicated. CpGs analyzed are indicated by black
arrows; numbers indicate distances (in bp) from the transcrip-
tion start site (TSS) of the gene (SH2D3C, NM 001252334.1) or
(FAM221A, XM 011515369.1). Y-axis represents % mCpG level for
each CpG site and X-axis represents distance (in bp) from TSS.
The CpG methylation level from the control samples (pUC19
transfection) was re-plotted as a reference. Each data point in
the graph represents the mean percentage of CpGs methylated
± SD (n = 2, independent transfections).
Supplementary Fig. S5. Effects of DNMT3B catalytic activity
and expression level on de novo TGFBR3 methylation. Bar charts
of % mCpG level for individual CpG sites of the TGFBR3 targeted
regions in dCas9 methyltransferase-expressing cells. Cells were
enriched by FACS 48 hours after transfection and sorted accord-
ing to the BPF signal: +, ++, +++, ++++. The schematic illus-
trations above the bar charts show gRNA binding sites and CpG
sites analyzed. Asterisk (∗) indicates statistical significance (P <
0.05, ANOVA) compared to the pUC19 control group after Bon-
ferroni correction. Percentage values represent % decrease of
TGFBR3 expression compared to pUC19.
Supplementary Fig. S6. WGBS analysis of cells expressing
dCas9 methyltransferase and gRNAs. (a) Summary of WGBS
including clean data, clean reads, clean rate, mapped reads,
uniquely mapped reads and rate, and bisulfite conversion rate,
for each experimental group and control (pUC19). (b) Average
percentage of methylated cytosine (% mC) for whole-genome
CpG sites, CHG sites, and CHH sites. “H” represents A, C, and
T. (c-d) Average mCpG level (percentage) stratified according to
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individual chromosome or whole genome for all samples mea-
sured by WGBS.
Supplementary Fig. S7. Differentially methylated regions
(DMRs) identified by DSS-single method. DMRs were categorized
as hypermethylated or hypomethylated compared to control
sample (pUC19 transfection).
Supplementary Fig. S8. Histogram charts of the distribution
of DMR length (bp), and number of CpGs per DMR. DMRs in-
cluded in this figure are those remaining after the stringent fil-
tering step (see methods). Mean DMRs length (in bp) and mean
number of CpG per DMR were given for each chart.
Supplementary Fig. S9. Genomic characteristics of off-target
DMRs caused by dCas9 methyltransferases and TGFBR3 gRNAs.
(a) Box plot (top) and heatmap clustering (bottom) of the hyper-
methylated (left) and hypomethylated (right) DMRs caused by
dCas9 methyltransferases and TGFBR3 gRNAs. (b-c) Bar chart il-
lustrating the percentage of the identified TGFBR3 hypermethy-
lated (c) or hypomethylated (d) DMRs that fall into the differ-
ent types of genomic regions indicated. Background represents
of a random sample of the same number of similar sized ge-
nomic windows that fall into the categories indicated. Values
above bars are P values between background and TGFBR3 DMRs,
Fisher’s exact test. (d) Metaplot of average CpG methylation lev-
els in 58 494 DNase I hypersensitive sites (DHS) and 1 kb up-
stream and downstream flanking regions. (e-f) Bar chart of %
TGFBR3 hypermethylated (f) or hypomethylated (g) DMRs falling
into DHS core regions. (h) Density of 5nt-SEED-NGG for TGFBR3
gRNAs (T1 to T3) in background genomic windows and TGFBR3
DMRs + flanking 100 bp. Values represent median density with
one standard deviation. P values (t-test) are given above the bar
charts.
Supplementary Fig. S10. Average methylation levels of seven
genomic regions in all annotated genes (hg19). (a-d) Each line
indicates the genome-wide average methylation levels across
seven genomic regions: upstream 2kb of the transcription start
site, first exon, first intron, internal exons, internal introns, last
exon, and downstream 2kb of the last exon.
Supplementary Fig. S11. The average methylation level in
ChIP-peaks and flanking regions. Bar chat presents the average
methylation level of all dCas9-BFP-DNMT3A and uPA gRNA off-
target binding sites (n = 7754) found by ChIPseq, as well as the
2kb upstream and downstream region.
Supplementary Fig. S12. Effect of dCas9 methyltransferases
and uPA gRNAs on cell growth. Cell growth was determined by
counting the number of cell clones derived from 1000 BFP pos-
itive cells after transfection. Values represent mean and one
standard deviation from 6 experimental repeats. Asterisks rep-
resent a P value < 0.05 (ANOVA) compared to pUC19 transfection
control.
Supplementary Fig. S13. Effects of dCas9 methyltransferases
on mCherry expression in fluorescence reporter cell lines. (a)
Schematic illustration of the mCherry fluorescence transgene
expression cassette. The target sites of the gRNAs within the
CMV promoter are indicated by red arrows (5′-3′, targeting sense
or antisense strands). (b) Southern blot analysis of five cell clones
with the transgene cassette randomly and stably integrated into
the genome. (c) Flow cytometry-based analysis of the percentage
of BFP positive cells in the fluorescence reporter cells at 2, 5, 8
and 14 days after transient transfection with CMV gRNAs (T1-
T3) and dCas9-BFP-DNMT1, dCas9-BFP-DNMT3A, dCas9-BFP-
DNMT3B, or dCas9-BFP-EGFP. (d-h) % mCherry fluorescence me-
dian intensity in these five clones at day 2, 5, 8, and 14 days
following transient transfection with CMV gRNAs (T1-T3) and
dCas9-BFP-DNMT1, dCas9-BFP-DNMT3A, dCas9-BFP-DNMT3B,
or dCas9-BFP-EGFP. Control cells were transfected with pUC19.
Percent inhibition of mCherry expression was calculated by nor-
malizing the median mCherry fluorescence intensity to that
from the pUC19 transfected cells at each time point. Figures are
plotted using the mean % mCherry median ± SD (n = 3, in-
dependent transfections). ANOVA with Bonferroni comparison
was performed for cell clone 2. “a,” “b,” “c,” and “d,” indicates
a P-value < 0.05 compared to the pUC19 control for the corre-
sponding transfection group.
Supplementary Fig. S14. Validation of hypermethylated
DMRs and DHS methylation caused by dCas9-BFP-DNMT3A and
uPA gRNAs byWGBS. (a) Box plot of %methylation level of hyper-
methylated DMRs dCas9 found in previous WGBS experiment.
TheWGBS in the repeat experiment was conducted as described
in the methods sections, but cells were not FACS enriched and
sequenced in lower depth than previous experiment. (b) Meta-
plot of average CpG methylation levels in 58 494 DNase I hyper-
sensitive sites (DHS) and 1 kb upstream and downstream flank-
ing regions. P value represents Wilcoxon matched pairs signed
rank test between treated and control groups.
Supplementary Table S1. List of plasmids deposited to Ad-
dgene, qPCR primers, gRNA sequences, bisulfite PCR primers,
bisulfite pyrosequencing primers, and DNA regions analyzed for
methylation.
Supplementary Table S2. List of hypermethylated DMRs
caused by dCas9 methyltransferases and uPA gRNAs
Supplementary Table S3. List of hypomethylated DMRs
caused by dCas9 methyltransferases and uPA gRNAs
Supplementary Table S4. List of hypermethylated DMRs
caused by dCas9 methyltransferases and TGFBR3 gRNAs
Supplementary Table S5. List of hypomethylated DMRs
caused by dCas9 methyltransferases and TGFBR3 gRNAs
Supplementary Table S6. List of binding peaks caused by
dCAs9-BFP-DNMT3A and uPA gRNAs
Supplementary File 1. Extended discussion and results.
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